Sage Journals: Discover world-class research

Retricted access

Research article

First published 2011-06

Target Therapy in HER2-Overexpressing Breast Cancer Patients

Rosalba Amodio, Maurizio Zarcone, Rosanna Cusimano [...]

OMICS: A Journal of Integrative Biology

Open access

Research article

First published 2015

Signaling Pathway of GP88 (Progranulin) in Breast Cancer Cells: Upregulation and Phosphorylation of c-myc by GP88/Progranulin in Her2-Overexpressing Breast Cancer Cells

Wes E. Kim, Binbin Yue, Ginette Serrero

Breast Cancer: Basic and Clinical Research

Open access

Research article

First published 2011

Delphinidin Inhibits HER2 and Erk1/2 Signaling and Suppresses Growth of HER2-Overexpressing and Triple Negative Breast Cancer Cell Lines

Tuba Ozbay, Rita Nahta

Breast Cancer: Basic and Clinical Research

Retricted access

Case report

First published 2019-9

Anti-Ri-associated paraneoplastic neurological syndrome: Initial symptom of breast cancer with HER2 overexpression and treatment by dual HER2 blockade

Omer Fatih Olmez, Oguzcan Kinikoglu, Nesrin Helvacı Yilmaz [...]

Journal of Oncology Pharmacy Practice

Free access

Review article

First published 2012-5

Improving survival and limiting toxicity: latest advances in treating human epidermal growth factor receptor 2 overexpressing breast cancer

Vandana G. Abramson, Ingrid A. Mayer

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2002-10

Development and Effects of Immunoliposomes Carrying an Antisense Oligonucleotide Against DHFR RNA and Directed Toward Human Breast Cancer Cells Overexpressing HER2

Mercè Rodríguez, Sílvia Coma, Véronique Noé [...]

Nucleic Acid Therapeutics

Retricted access

Research article

First published 2022-06

Clinical Dose Preparation of [ 177 Lu]Lu-DOTA-Pertuzumab Using Medium Specific Activity [ 177 Lu]LuCl 3 for Radioimmunotherapy of Breast and Epithelial Ovarian Cancers,with HER2 Receptor Overexpression

Sreeja Raj Menon, Arpit Mitra, Avik Chakraborty [...]

Cancer Biotherapy and Radiopharmaceuticals

Open access

Review article

First published 2014

Current Approaches and Emerging Directions in HER2-resistant Breast Cancer

Adam M. Brufsky

Breast Cancer: Basic and Clinical Research

Retricted access

Research article

First published 2018-1

Specific targeting of human epidermal growth factor receptor 2 (HER2) overexpressing breast cancer cells by polyethylene glycol-grafted polyethyleneimine modified with anti-HER2 single-domain antibody

Batoul Saqafi, Fatemeh Rahbarizadeh

Journal of Bioactive and Compatible Polymers

Open access

Review article

First published 2016

Mechanisms behind the Resistance to Trastuzumab in HER2-Amplified Breast Cancer and Strategies to Overcome It

Maria Luque-Cabal, Paula García-Teijido, Yolanda Fernández-Pérez [...]

Clinical Medicine Insights: Oncology

Search results